Administration of second dose of vaccine product containing only five component acellular bordetella pertussis, clostridium tetani, corynebacterium diphtheriae, haemophilus influenzae type b and inactivated whole human poliovirus antigens (procedure)
SCTID: 415507003, Primitive, Active
415507003|Administration of second dose of vaccine product containing only five component acellular bordetella pertussis, clostridium tetani, corynebacterium diphtheriae, haemophilus influenzae type b and inactivated whole human poliovirus antigens (procedure)|
- en Administration of second dose of diphtheria and haemophilus influenza type b and five component acellular pertussis and inactivated poliomyelitis and tetanus vaccine
- en Administration of second dose of vaccine product containing only five component acellular bordetella pertussis, clostridium tetani, corynebacterium diphtheriae, haemophilus influenzae type b and inactivated whole human poliovirus antigens
- en Administration of second dose of vaccine product containing only five component acellular bordetella pertussis, clostridium tetani, corynebacterium diphtheriae, haemophilus influenzae type b and inactivated whole human poliovirus antigens (procedure)
- en Second diphtheria and haemophilus influenza type b and five component acellular pertussis and inactivated poliomyelitis and tetanus immunisation
- en Second diphtheria and haemophilus influenza type b and five component acellular pertussis and inactivated poliomyelitis and tetanus immunization
- en Second diphtheria and haemophilus influenza type b and five component acellular pertussis and inactivated poliomyelitis and tetanus vaccination